Emyria’s data-backed cannabinoid treatments are changing lives
Emyria Limited (ASX: EMD) is an Australian drug development company that focuses on novel treatments for patients with unmet medical...
News
Medical Healthcare
News
Regulatory changes blaze path for Australian Cannabis industry
Australia’s blossoming medicinal cannabis industry is poised for a year of growth following regulatory changes made by the Therapeutic Goods...